Loading Events

Multi-organ impact: Harnessing the benefits of SGLT2 inhibitors

Quick summary – Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Faculty

Pinar Topsever

Primary Care Physician,

Acıbadem University School of Medicine, Turkey

Waqas Tahir

Primary Care Physician,

West Yorkshire and Harrogate Health, UK

Ana Cebrián

Primary Care Physician,

San Antonio Catholic University San Antonio (Murcia), Spain

Agenda

Duration (mins)Session titleFaculty
10Welcome and introductionPinar Topsever
10Where is your CKD patient?Pinar Topsever
15SGLT2 inhibitors: a primary care treatment in CKDWaqas Tahir
10Practical considerations for CKD management: time to think differentlyAna Cebrian
10Panel discussion and Q&AAll faculty
5Summary and close Pinar Topsever

Please note you must register for the 16th International Primary Care Diabetes Europe Conference to access this event.Register for PCDE conference here: https://www.pcdeurope.org/calendar/16th-international-primary-care-conference/

The educational content is intended for Primary Care Physicians.

This symposium is endorsed by Leicester Diabetes Centre and accredited for 1 CPD credit by the Royal College of Physicians.

Supported by an unrestricted educational grant from AstraZeneca.